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Abstract
Background: Chromosomal deletions are used extensively in Drosophila melanogaster genetics research. Deletion
mapping is the primary method used for fine-scale gene localization. Effective and efficient deletion mapping
requires both extensive genomic coverage and a high density of molecularly defined breakpoints across the
genome.
Results: A large-scale resource development project at the Bloomington Drosophila Stock Center has improved the
choice of deletions beyond that provided by previous projects. FLP-mediated recombination between FRT-bearing
transposon insertions was used to generate deletions, because it is efficient and provides single-nucleotide
resolution in planning deletion screens. The 793 deletions generated pushed coverage of the euchromatic genome
to 98.4%. Gaps in coverage contain haplolethal and haplosterile genes, but the sizes of these gaps were minimized
by flanking these genes as closely as possible with deletions. In improving coverage, a complete inventory of
haplolethal and haplosterile genes was generated and extensive information on other haploinsufficient genes was
compiled. To aid mapping experiments, a subset of deletions was organized into a Deficiency Kit to provide
maximal coverage efficiently. To improve the resolution of deletion mapping, screens were planned to distribute
deletion breakpoints evenly across the genome. The median chromosomal interval between breakpoints now
contains only nine genes and 377 intervals contain only single genes.
Conclusions: Drosophila melanogaster now has the most extensive genomic deletion coverage and breakpoint
subdivision as well as the most comprehensive inventory of haploinsufficient genes of any multicellular organism.
The improved selection of chromosomal deletion strains will be useful to nearly all Drosophila researchers.
Background
Chromosomal deletions are important to experimental
genetic analysis in two fundamental ways. First, dele-
tions fail to complement loss-of-function mutations in
genes located in the chromosomal region of the dele-
tion. This noncomplementation is the basis for using
deletions to map mutations to specific chromosomal
regions, to screen for new mutations in closely linked
sets of genes and to assess the allelic strengths of new
mutations. Second, heterozygous deletions can enhance
or suppress mutant phenotypes. Reducing the copy
number of one gene can modify the phenotype caused
by abnormal expression of another gene involved in the
same biological process. Modifier screens are a powerful
way to identify suites of genes involved in related
genetic pathways. Drosophila melanogaster tolerates het-
erozygous deletions of large numbers of genes quite well
and its chromosomes are easy to manipulate in vivo;
consequently, deletions are used more extensively in
genetic experiments with D. melanogaster than other
organisms. Indeed, fine-scale mapping approaches based
on meiotic recombination such as SNP mapping are not
used widely in fly research, because they are less conve-
nient and precise. Consequently, chromosomal deletion
stocks are the most heavily used class of stocks distribu-
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(BDSC). The demand for a better selection of deletions
led us at the BDSC to undertake the large-scale research
resource development project described here.
Many methods have been developed for isolating dele-
tions in Drosophila. Early methods employed chemical
mutagens or irradiation to produce random chromoso-
mal breakpoints. Deletions in specific chromosomal
regions were identified by their failure to complement a
recessive mutation, by removal of a gain-of-function
mutation, or from dominant effects of reduced gene
copy number. Obtaining a deletion of a particular size
in a desired location was difficult because the mutagen-
eses were inefficient and the positions of breakpoints
could not be controlled. Later methods relied on trans-
posons to target deletions to particular chromosomal
regions. Deletions flanking P and Minos elements result
from defective transposition events when attempts are
made to remobilize the transposons and deletions flank-
ing Hobo elements result from recombination between
Hobo copies following local transpositions [1-6]. While
one to two orders of magnitude more efficient than che-
mical or irradiation screens, transposon remobilization
screens still have the disadvantage of breakpoint unpre-
dictability. The positions of breakpoints are typically
confined to a small chromosomal region, but they can-
not be directed with single-nucleotide certainty. Further-
more, mechanistic constraints make it difficult to obtain
large deletions in most remobilization screens.
A more recent method for generating deletions
employs FLP recombinase to catalyze recombination
between FRT sequence elements carried on transposable
elements [7]. It is one to two orders of magnitude more
efficient than transposon remobilization, the positions of
breakpoints can be predicted at the nucleotide level and
there are no inherent limitations on deletion size other
than aneuploidy effects. This method has been adopted
enthusiastically by Drosophila geneticists because it has
made the isolation of large, multigene deletions and
small, single-gene knockouts relatively easy.
There have been three large-scale projects generating
deletions using FLP-FRT technology. The DrosDel Pro-
ject generated a large collection of insertions of the
FRT-bearing transposons P{RS3} and P{RS5} [8] and
used them in screens that provided 357 deletion stocks
now in the BDSC collection [9]. Exelixis, Inc. generated
a larger insertion collection of the FRT-bearing con-
structs P{XP}, PBac{RB} and PBac{WH} [10] and isolated
433 deletions now distributed by the BDSC [5]. These
two deletion collections were generated independently
and the deletions from these projects being distributed
by the BDSC together provide 78% coverage of Droso-
phila euchromatin.
The third deletion project was undertaken at the
BDSC and it is the subject of this paper. We began
generating deletions before FLP-FRT technology for
deletion screening was generally available. At the time,
genomic coverage of approximately 71% was provided
by chemical- or irradiation-induced deletions. We were
able to provide novel coverage of 5 to 7% of the genome
using a P element remobilization approach [5], but we
retooled our project when the Exelixis FRT-bearing
insertions were placed into the public domain [10,11].
As we will show, our efforts using the improved tech-
nology have resulted in total euchromatic coverage of
98.4%.
To provide such extensive deletion coverage, it was
necessary to identify all genes needed in two copies for
normal viability and fertility. These haploinsufficient
genes are the only barriers to complete deletion cover-
age in the absence of compensating chromosomal dupli-
cations and our work provides the first comprehensive
inventory of these genes in Drosophila melanogaster.
Most remaining gaps in deletion coverage contain a
haploinsufficient gene and, because we flanked these
genes as closely as possible with pairs of deletions, the
gaps are all quite small.
To make it easier for geneticists to take advantage of
this broad deletion coverage, the BDSC distributes the
‘Deficiency Kit’, a selected set of deletions providing
maximal genomic coverage with a minimal number of
stocks. Here we will describe a new, improved Defi-
ciency Kit composed primarily of molecularly defined
deletions from the three deletion projects. It replaces
the original Deficiency Kit that consisted of older dele-
tions characterized only at the level of chromosome
banding.
While the fraction of the genome covered by deletions
in aggregate determines their effectiveness in initially
localizing genes, the density of deletion breakpoints
determines the resolution of deletion mapping. The
more finely the genome is subdivided by breakpoints,
the easier it is to map a mutation or genetic modifier to
a specific transcription unit. For this reason, we have
also worked to improve the distribution of breakpoints
across the genome. Because of our efforts, the median
interval between breakpoints is now only nine genes and
nearly 400 single-gene intervals have been defined.
In brief, we accomplished three goals. First, we
improved deletion coverage of the D. melanogaster gen-
ome substantially and, in the process, provided a com-
plete catalog of haplolethal and haplosterile genes.
Second, we updated the Bloomington Deficiency Kit by
replacing most chemical- or irradiation-induced dele-
tions with molecularly defined deletions isolated from
FLP-FRT screens. Finally, we improved the resolution of
deletion mapping by increasing the density of molecu-
larly defined breakpoints across the genome. The result
is a collection of deletions at the BDSC for the rapid
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and efficient mapping of mutations and modifier loci
that is unparalleled among multicellular organisms.
Results
Generating molecularly defined deletions by FLP-
mediated recombination
The system for generating deletions devised at Exelixis
involves the use of three FRT-bearing transposon con-
structs (Figure 1a) [5,10]. Each construct carries the
miniwhite marker and at least one FRT sequence. Dele-
tions can be recovered by combining pairs of insertions
in trans in the presence of an inducible genomic source
of FLP recombinase. FLP-mediated recombination gen-
erates a deletion if the FRT sequences are arranged in
the same relative orientation. If the miniwhite markers
lie internal to the FRT sequences, deletion-bearing pro-
geny will have white eyes from elimination of both
copies of miniwhite upon recombination (Figure 1b). If
they lie external to the FRTs, deletion-bearing progeny
often have darker eyes than flies in either single-FRT
progenitor strain from the presence of two copies of
miniwhite (Figure 1c). We generated 87% of our dele-
tions using construct combinations eliminating mini-
white markers; the remaining deletions were isolated in
P{XP}

























Figure 1 Generating molecularly defined deletions using Exelixis FRT-bearing transposon insertions. (a) The structure of the P{XP}, PBac
{RB}and PBac{WH} constructs. The miniwhite-marked P element or piggyBac (PBac) constructs carry one or two FRT sequences with the indicated
orientations. (miniwhite is a version of the white gene engineered for compact size.) P{XP} and PBac{WH} constructs also carry UAS sequences
oriented to allow GAL4-induced expression of genes near the genomic insertion sites of the constructs. One UAS sequence in P{XP} can be
removed by FLP-mediated recombination and it is likely that this cassette is absent from most deletion chromosomes, though we did not assay
for it in our deletion chromosomes. (b-d) Simplified diagrams of FLP-mediated recombination events generating deletion chromosomes with
different miniwhite copy numbers. (b) Our most frequently used screening strategy, where deletions are identified based on loss of miniwhite
and the resulting white eye color. (c) The alternative strategy of identifying deletions based on increased miniwhite copy number relative to
progenitor chromosomes and the resulting darker eye color. (d) Deletions can be recovered without a decrease or increase in miniwhite copy
number, though we did not undertake such screens.
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progeny bearing two copies of miniwhite. Pairs of inser-
tions can also be used to recover deletions with no net
gain or loss of miniwhite markers (Figure 1d), but such
screens were not attempted in this project.
Approximately 16,500 FRT-bearing transposon inser-
tions on the X chromosome and autosomes were gener-
ated and placed into public distribution by Exelixis
[10,11]. The density of insertions afforded by such a
large collection gave us flexibility in designing deletions.
As we will describe below, convenient insertions were
usually available so that we could flank haploinsufficient
genes closely with pairs of deletions in our efforts to
maximize deletion coverage and improve the distribu-
tion of breakpoints. In some chromosomal regions, how-
ever, the scarcity of insertions limited our efforts.
We isolated 793 deletions. They are described in detail
in Additional file 1 and their breakpoint positions are
shown relative to annotated genes in Additional file 2.
Because we were primarily concerned with breakpoint
placement, we did not standardize the size of the dele-
tions. We did not generate deletions with heterochro-
matic breakpoints because most heterochromatic P{XP},
PBac{WH} and PBac{RB} insertions have not been loca-
lized unambiguously. In the screens that were successful,
one deletion was recovered for every approximately 50
progeny screened with a range of roughly 1 in 10 to 1
in 1,000. We retained only one deletion from each
screen for the BDSC collection.
We confirmed the existence of deletions by demon-
strating that genes located between the progenitor inser-
tions were missing. We usually designed deletions so
they encompassed at least one gene with an existing
loss-of-function mutation to use in complementation
tests. Only two deletions designed early in the project
were small enough to avoid removing vital genes. We
also used preexisting deletions in complementation tests
with new deletions if the progenitor FRT-bearing inser-
tions were not themselves homozygous lethal to demon-
strate that at least one vital gene was deleted. If an
appropriate complementation test was not available, we
verified the presence of a deletion by polytene cytology
or by demonstrating that a particular internal DNA frag-
ment could not be PCR amplified from the deletion
chromosome. Eighteen new deletions showed dominant
phenotypes expected for deleting known haploinsuffi-
cient genes (Additional file 1).
We also verified that the expected deletion event
occurred using the ‘hybrid PCR’ method [5]. In brief,
PCR primers within each FRT-bearing progenitor inser-
tion can amplify a fragment only if they are juxtaposed
by FLP-mediated recombination. We tested 93% of the
deletions lacking miniwhite markers by this method and
all gave the expected result (Additional file 1). We used
a positive hybrid PCR test as the sole criterion for
verifying only six deletions; all other deletions were also
confirmed on the basis of deleted genes or sequences.
The Exelixis insertions were generated in a uniform
genetic background [10] and we maintained this back-
ground in most deletion screens as described in Parks et
al.[5]. Noninsertion chromosomes specific to our
screens were substituted into the standard background
prior to use. Minimizing genetic variability in the dele-
tion stocks makes them more valuable in the analysis of
background-sensitive phenotypes such as behavioral
traits. It was necessary to establish 27 deletions in stock
with nonstandard balancers due to dominant effects of
the deletions on viability or fertility or due to noncom-
plementation with mutations on standard balancers
(Additional file 1).
Deletion stocks were placed into public distribution as
soon as the deletions were verified; consequently, many
deletions have been in widespread use for years and
have contributed to published research (for examples,
[12-18]). Details of each deletion screen have been
documented in FlyBase and references to the individual
reports are given in Additional file 1. FlyBase developed
a graphical interface for viewing molecularly defined
deletions during our project [19] and the BDSC website
lists available deletions [20].
We conducted 708 screens that produced no deletions
and we were often able to determine the cause of the
failure. First, the rate of recovering deletions was often
low. We were able to generate most deletions with mod-
est-sized screens, but some deletions required larger
screens. Four percent of deletions were recovered only
after additional rounds of screening. Five percent of the
screens failed even though both progenitor insertions
had been used in successful screens, there was no hap-
loinsufficient gene in the region and the deletion would
not have been particularly large, suggesting small screen
size as the most likely explanation for failure. Second,
the insertions in many stocks did not map as described.
We saw evidence that insertions were mismapped in
12% of the unsuccessful screens. (All eight of the fourth
chromosome deletion screens were in this category, sug-
gesting that a high proportion of the fourth chromo-
some insertion stocks are not as represented. We
abandoned plans for additional screens without validat-
ing the remaining putative fourth chromosome insertion
stocks.) Third, in 6% of the failed screens, putative dele-
tions could not be established in stock due to lethality
and/or sterility, even though no haploinsufficient genes
existed in the region. We suspect that the abnormal jux-
taposition of genic regions upon deletion results in dele-
terious neomorphic phenotypes more often than is
generally appreciated. Fourth, 5% of unsuccessful
screens failed because flies in the intermediate crosses
were weak, sterile or dead. We attribute these problems
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to noncomplementation and dominant interactions
between mutations in the stocks. Fifth, 10% of unsuc-
cessful screens failed because we intentionally deleted
haploinsufficient genes. (We will discuss these experi-
ments below.) The remaining screens probably failed
from small screen sizes or mismapped insertions. They
all involved at least one insertion stock that had not
been used successfully in another screen. From these
experiences, we recommend that anyone planning FLP-
FRT screens verify the positions of progenitor insertions,
plan screens larger than our routine screen sizes and, if
possible, attempt to create deletions of a region using
more than one combination of progenitor insertions.
False positives were recovered in many screens. For
example, white-eyed progeny carrying no deletion were
recovered in screens designed to eliminate the miniwhite
markers from both progenitor insertions upon FLP-
mediated recombination (Figure 1b). While false posi-
tives did not prevent the recovery of deletions, they
increased the workload in the verification step. At least
9% of screens successfully producing deletions also pro-
duced false positives. Inexplicably, X chromosome
screens were much more likely to give false positives
than autosomal screens (49% versus 4%). At least 23% of
the screens producing no deletions gave false positives,
again, with a disproportionate number involving the X
chromosome rather than an autosome (56% versus
15%). False positives were also seen in Exelixis and
DrosDel screens (A Parks, personal communication) [9].
Consequently, we recommend testing multiple putative
deletions in all screens. Though the false positives have
not been characterized in detail, we surmise they origi-
nate from the repair of DNA damage associated with
abnormal FLP-mediated recombination events.
Improving deletion coverage of the genome
The first goal of our project was to improve deletion
coverage of the genome. As summarized in Table 1 and
shown in detail in Additional file 2, 98.4% coverage of
euchromatic genes is now available using deletions
distributed by the BDSC regardless of their origin. The
deletions we generated (the ‘BSC’ deletions) encompass
81.5% of euchromatic genes as compared to 65.2% for
the DrosDel deletions at Bloomington and 47.4% for the
Exelixis deletions. Together, the molecularly defined
deletions from the three large-scale projects provide
94.9% coverage with 17.9% of euchromatic genes
removed exclusively by BSC deletions. The remaining
genomic coverage is provided by chemical- or irradia-
tion-induced deletions (3.4%) and FRT-derived deletions
from individual investigators (0.1%).
The single biological impediment to complete deletion
coverage is the existence of genes that must be present
in more than one copy for viability and fertility. Dele-
tions of these haplolethal and haplosterile genes cannot
be recovered in the absence of a compensating chromo-
somal duplication. (Obviously, haploinsufficiency per-
tains to X-linked genes only in females where two gene
copies are normally present.) Duplications had been iso-
lated for some haplolethal and haplosterile genes before
we began our work, but generating new duplications in
order to screen for deletions was beyond the scope of
this project. Instead, we generated pairs of deletions to
flank haplolethal and haplosterile genes as closely as
possible as a way to maximize deletion coverage. This
strategy allowed us to improve coverage substantially,
but it precluded 100% coverage. The sizes of gaps in
coverage were determined by the availability of FRT-
bearing transgene insertions; consequently, some genes
closely linked to haplolethal and haplosterile genes also
remain undeleted. We chose not to use preexisting
duplications to screen for deletions of haploinsufficient
genes because we wanted to preserve a consistent
genetic background in our deletion stocks. We were
also aware of the fact that deletions of haploinsufficient
genes have limited experimental value: the phenotypes
of haploinsufficient genes often confound the interpreta-
tion of complementation tests and they enhance so
many other mutant phenotypes that they are generally
viewed as nuisances in modifier screens.

















X 82.7 18.0 57.6 92.3 26.9 5.9 98.1
2L 70.5 68.2 71.7 96.0 12.0 3.0 98.9
2R 88.5 45.7 52.4 95.9 26.8 2.3 98.2
3L 84.1 39.3 69.4 95.3 15.3 2.5 97.5
3R 83.0 59.6 73.0 95.7 11.4 3.2 98.9
4 0 0 54.1 54.1 0 42.4 96.5
Total 81.5 47.4 65.2 94.9 17.9 3.5 98.4
aCoverage by Exelixis or DrosDel deletion stocks maintained at the BDSC. Some deletions reported by Exelixis [5] were false positives; stocks for other deletions
were lost. Stocks for some DrosDel deletions [9] were too weak to maintain. bCoverage provided by BSC deletions, but not Exelixis or DrosDel deletions.
cChemical- or irradiation-induced deletions plus FRT-derived deletions from individual investigators.
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If we consider the distribution of deletion breakpoints
for the DrosDel, Exelixis and BSC deletions, we see
there is a total of 81 gaps in deletion coverage across
the entire euchromatic genome (Additional file 2). Fifty-
five gaps contain haploinsufficient genes, five gaps
(including three with haploinsufficient genes) lie adja-
cent to centric heterochromatin where screening was
not possible, three gaps (including one with a haploin-
sufficient and one adjacent centric heterochromatin) lie
on the fourth chromosome where we recovered no dele-
tions and 23 gaps are not covered despite the absence of
haploinsufficient genes. The median size of the gaps is
only 7 genes and the gaps range in size from 1 to 36
genes (1 to 27 if a large fourth chromosome gap is dis-
regarded). We made multiple attempts to provide dele-
tion coverage for most gaps lacking haplolethal or
haplosterile genes, but we were unsuccessful for the rea-
sons outlined above.
Fortunately, many gaps in coverage between BSC, Exe-
lixis and DrosDel deletions are covered by older dele-
tions or FRT-derived deletions from individual
investigators. We have no clear explanation for the fail-
ure of FLP-FRT screens in regions where older deletions
provided coverage. Although the haplosterility or haplo-
lethality of some genes might depend on genetic back-
ground, it is unlikely this is the case for a large number
of genes. Screens with different progenitor insertions to
the ones we used might prove successful. When dele-
tions from all sources are considered - including those
maintained in stock with a duplication - only 35 gaps in
coverage remain. {AU comment: It seems to me that em
dashes should be used here rather than hyphens.}Thirty-
two gaps contain haploinsufficient genes, three gaps
(including one with a haploinsufficient gene) lie adjacent
to centric heterochromatin, and two gaps (including one
adjacent to centric heterochromatin) lie on the fourth
chromosome. The median gap size is 7 genes with a
range of 1 to 18 genes. We verified that the older dele-
tions span gaps with complementation tests and PCR
amplifications. In many cases, these verification experi-
ments also allowed us to map deletion breakpoints of
the older deletions more precisely (Additional file 2). In
addition, the breakpoints of three gap-covering deletions
(Df(2L)C144, Df(2R)CX1 and Df(3L)ZN47) were mapped
with comparative genomic hybridization microarrays at
the same time breakpoints of X chromosome duplica-
tions from another BDSC resource project were loca-
lized [21].
Identifying haploinsufficient genes
Although it was necessary to identify haplolethal and
haplosterile genes in order to improve deletion coverage,
most were poorly mapped and few had been associated
with annotated genes when we began our project.
Consequently, the process of planning deletion screens
was intertwined with the task of identifying haploinsuffi-
cient genes. When there were no hints about the mole-
cular identity of a haploinsufficient gene, we faced the
tedious process of iterative deletion screening to narrow
its location.
Fortunately, most haploinsufficient genes in Droso-
phila encode protein components of cytoplasmic ribo-
somes (Rp genes) or translation initiation factors (eIF
genes) and are associated with the Minute syndrome, a
characteristic set of phenotypes including short, thin
bristles and slower development [22]. All Minute genes
are associated with some degree of haplolethality and
haplosterility, but the phenotypes of many Minute genes
are not severe enough to prevent the recovery of dele-
tions in the absence of duplications. We assured that all
Minute genes were flanked as closely as possible with
deletions and we attempted to delete 34 Minute genes
to assess their viability and fertility. Deletions for 7 Min-
ute genes could be established in simple heterozygous
stocks, but deletions for the remaining 27 could not be
recovered or heterozygous stocks were too weak to
maintain long term. We did not attempt to delete Min-
ute genes where evidence already existed for strong leth-
ality or sterility effects. Table 2 shows Minute genes
with viability or fertility effects strong enough to prevent
the recovery of deletions in the absence of a duplication;
Table 3 shows Minute genes with weaker effects.
Because Minute phenotypes lie on a continuum and
vary by genetic background, genes with intermediate
effects might be classified differently in other experi-
ments. Additional files 2 and 3 provide details of dele-
tion coverage near Minute genes. This inventory
updates the number of Minute loci given in Marygold et
al.[22] from 65 to 66 with the reclassification of RpL23.
Nine haplolethal or haplosterile loci do not encode ribo-
some-associated proteins (Table 2; Additional files 2 and
3). Four of the non-Minute genes (Fs(1)10A, Hdl, the
unnamed haplolethal in 67DE and Ms(3)88C) have not
been mapped to single transcription units, but the Dros-
Del Project localized Ms(3)88C to a small region by suc-
cessive rounds of screens [9] and we localized Fs(1)10A,
Hdl and the 67DE haplolethal similarly. The Tpl locus cor-
responds to a repetitive gene cluster [23]. We defined a
small region within the Tpl cluster that could not be
further narrowed by deleting from the proximal and distal
sides using the available FRT insertions, but it is possible
that viability simply requires a minimal number of gene
repeats. Thirty-five of our failed screens were devoted to
mapping these non-Minute haploinsufficient loci.
Tables 2 and 3 present comprehensive inventories of
haplolethal, haplosterile and Minute genes in D. melanoga-
ster, but we also compiled a list of haploinsufficient genes
associated with developmental or cellular phenotypes that
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do not affect viability or fertility enough to prevent the
recovery of deletions (Table 4; Additional file 2). All were
removed by molecularly defined deletions, but we made
no attempt to flank these genes closely with deletions.
Only the Hup locus has not been mapped to a transcrip-
tion unit. We did not identify new haploinsufficient genes


























































































aA Minute phenotype results from deleting chromosomal region 93A, but it
may be associated with haploinsufficiency of RpS20, RpS30 or both genes.




aA Minute phenotype results from deleting chromosomal region 60B, but it
may be associated with haploinsufficiency of RpL12, RpL39 or both genes.
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with obvious external morphological phenotypes and few
are likely to exist. Additional haploinsufficient genes with
cellular phenotypes may have been described in the litera-
ture and others will probably be identified in the future, so
Table 4 is undoubtedly incomplete. We do not know how
many haploinsufficient genes might exist with moderate
viability or fertility effects similar to the Minute genes in
Table 3 yet have no obvious external morphological
effects.
The non-Minute haploinsufficient genes listed in
Tables 2 and 4 implicate no single biological pathway or
process, though there are a few discernable themes. The
largest subset encodes the muscle components actin
(Act88F), myosin (Mhc and Mlc2) and tropomyosin
(Tm2) as well as a group of closely linked, muscle-
related genes regulated by a haplolethal sequence within
an intron of the Troponin I (wupA) gene [24]. This sub-
set may also include Hdl, which may correspond to Tro-
ponin T (up) [21,25]. Like the ribosomal protein genes,
these genes may be particularly dosage sensitive because
muscle assembly requires minimal levels or a particular
stoichiometry of component proteins [22,24,26]. Other
definable subsets encode homeodomain proteins (Abd-
B, Dll, Scr and Ubx), Notch pathway components (Dl, H
and N), Polycomb group repressor proteins (Pc and Pcl),
apoptosis regulators (lok and p53) and melanin biosyn-
thetic enzymes (b and e).
Assembling a new Deficiency Kit
For years, the BDSC has maintained and distributed a
set of deletions providing maximal genomic coverage
using the fewest deletions deemed practical. The ‘Defi-
ciency Kit’ was established before FLP-FRT deletions
existed and deletions were added to the original deletion
set when they provided novel coverage. Consequently,
the kit consisted mostly of deletions with breakpoints
mapped only at the level of polytene cytology. With
large collections of molecularly defined deletions avail-
able, the kit had become outdated.
As the second goal of our project, we created a new
Deficiency Kit and began distributing it in July 2009
while we were still screening for new deletions. We chose
a tiling path of FRT-derived deletions from the three
deletion projects and from individual investigators to
provide maximal coverage. The remaining gaps in cover-
age were filled with older deletions where possible. In
many cases, the older deletions were maintained in stock
with duplications, allowing us to delete many regions
containing haploinsufficient loci. To create a kit better
suited for genetic modifier screens, we included the dele-
tion pairs most closely flanking haploinsufficient genes
even when they were removed completely by older dele-
tions. Older deletions also allowed us to cover hetero-
chromatic regions where FLP-FRT deletions currently do
not exist and the fourth chromosome where few molecu-
larly defined deletions exist. As we generated new dele-
tions, we updated and improved the kit. Table 5 shows a
Table 4 Haploinsufficient loci with developmental or
cellular phenotypes not associated with strong
haplolethality or haplosterility
Gene Location Phenotype Referencea
N 3C7-9 Wing notching [47]
Hupb 7BC Pronotal outgrowth [48]
run 19E2 Segmentation defects [49]
S 21E4 Eye roughness [50]
Pkd2 33E3 Reduced smooth muscle
contractility
[51]
b 34D1 Darker body color [52]
Mhc 36B1 Muscle defects [53]
lok 38B2 No apoptosis after telomere loss [54]
vg 49E1 Wing notching [55]
Np/
CG34350c
45A1 Notopleural bristle length [56]
Pcl 55B8 2nd to 1st leg transformation [57]
bsd 60C6 Wing venation defects [58]
Dll 60E2 Antenna to leg transformation [59]
Kr 60F5 Segmentation defects [60]
mtrm 66C11 Increased female nondisjunction [61]
Pc 78C6-7 2nd to 1st leg transformation [62]
Scr 84A5 1st to 2nd leg transformation [63]
Tm2 88E13 Muscle defects [64]
Act88F 88F5 Muscle defects [65]
Ubx 89D9 Haltere to wing transformation [66]
Dl 92A1-2 Wing venation defects [67]
bnl 92B2-3 Abnormal tracheal branching [68]
H 92F3 Bristle shaft to socket
transformation
[33]
e 93C7-D1 Darker body color [48]
p53 94D10 No apoptosis after telomere loss [54]
Mlc2 99E1 Muscle defects [69]
aReference originally describing haploinsufficiency. bHumeral patch (Hup) is
the only locus in this list not mapped to a specific transcription unit. cAllelism
of Notopleural (Np) and CG34350 demonstrated by Laurence von Kalm
(personal communication). dPlexate (Px) is a haploinsufficient locus closely
linked or allelic to blistered (bs) with similar phenotypes. We have assumed
allelism.
Table 5 The Bloomington Deficiency Kit











aOne stock carries deletions in both 3L and 3R.
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summary of genomic coverage provided by the current
kit. Additional file 4 lists the contents of the Deficiency
Kit and Additional file 2 shows the deletion breakpoints
relative to annotated genes. Information on the Defi-
ciency Kit is also provided on the BDSC website [27].
Because the average size of the DrosDel, Exelixis and
BSC deletions is smaller than the average size of the
deletions in the previous Deficiency Kit, the new kit is
larger (468 versus 271 deletions). Nevertheless, the
advantages of molecularly mapped breakpoints and con-
sistent genetic backgrounds offset the inconvenience of
handling more stocks in experiments. As we will show
in the next section, once a phenotype is mapped to a
chromosomal interval using the new Deficiency Kit, its
position can be narrowed to a very small interval or
even a single transcription unit using additional molecu-
larly defined deletions.
Extensive subdivision of the genome with deletion
breakpoints
When a gene is mapped with deletions, it is usually
localized to a chromosomal interval defined by adjacent
breakpoints of different deletions rather than the break-
points of a single deletion. For example, a mutation
would map between the distal breakpoints of two over-
lapping deletions if it complemented the proximal dele-
tion but not the distal deletion. Consequently, the
critical factor determining the resolution of deletion
mapping is the density of deletion breakpoints rather
than deletion size.
The third goal of our project was to improve the dis-
tribution of deletion breakpoints across the genome and
our target was to generate deletions so that the intervals
between adjacent breakpoints would contain no more
than a dozen protein-coding genes. We examined the
distribution of breakpoints provided by the DrosDel and
Exelixis deletions and undertook screens to interpose
new breakpoints between them (Additional file 2).
Figure 2 shows the distribution of interval sizes provided
by deletions from the three projects. To construct this
distribution, we assigned every euchromatic gene a posi-
tion between adjacent deletion breakpoints based on
where it would map uniquely if a mutation in the gene
were complementation tested with the deletions. These
hypothetical complementation tests allowed us to assign
a gene to a single interval even when a deletion break-
point fell within the gene. The median interval size for
the entire genome is nine genes. The median interval
size for chromosome arms X, 2R, 3L and 3R is also nine
genes, but the median size for 2L, where there are more
FRT-derived deletions, is only seven genes.
Many intervals exceeded our target size of 12 genes,
though the largest interval contains only 36 genes (it lies
on the fourth chromosome, where our screens were
unsuccessful; the largest interval elsewhere contains 27
genes). The largest intervals could not be subdivided
because no FRT-bearing transposon insertions existed in
the interval or repeated attempts to subdivide the region
with existing insertions failed. Other intervals exceeded
our target size because gene annotations changed in the
course of the project or because we counted genes for
noncoding RNAs such as microRNAs and small nucleo-
lar RNAs, which we did not consider in planning the
deletion screens due to their poor annotation at the
time.
As Figure 2 shows, it is now possible to map most
mutations and genetic modifiers to very small groups of
candidate transcription units with simple crosses. The
deletion breakpoints even define 377 single-gene inter-
vals. This degree of genomic subdivision makes deletion
mapping the method of choice for most gene localiza-
tion experiments in D. melanogaster.
Discussion
The enormous benefit of using FLP-mediated recombi-
nation between FRT-bearing transposon insertions to
generate chromosomal deletions is absolute predictabil-
ity. Deletion breakpoints can be positioned with single-
nucleotide certainty. Homologous recombination meth-
ods [28] are the only other approaches in D. melanoga-
ster allowing one to plan deletion screens with such
precision. The advent of these molecularly defined dele-




















































Number of genes between deletion breakpoints
Figure 2 Frequency distribution of the number of genes
between molecularly defined deletion breakpoints. The number
of genes in a chromosomal interval between adjacent deletion
breakpoints is shown on the x-axis and the number of intervals in
the Drosophila genome with those sizes is shown on the y-axis.
Because BSC, Exelixis and DrosDel deletions overlap extensively, the
intervals were usually defined by breakpoints of different deletions.
The median interval size is only nine genes. For simplicity, the
Stellate gene cluster in chromosomal region 12E, the histone gene
cluster in 39D and the 5S rRNA gene cluster in 56E were counted as
single genes.
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mapping. Previously, the breakpoints of most deletions
had been mapped only at the resolution of polytene
chromosome analysis, which, even at its best, positioned
breakpoints in relatively large chromosomal intervals.
The uncertainty of breakpoint positions in older dele-
tions made high-resolution mapping difficult. In con-
trast, deletion mapping with FLP-FRT deletions is
straightforward and unambiguous. The obvious advan-
tages of these deletions led to their immediate and
enthusiastic adoption by Drosophila geneticists. While
the older deletions are still valuable, they are not used
as frequently as they once were. Approximately 85% of
deletion stocks currently ordered from the BDSC are
FRT-derived deletions.
Our project at the BDSC was one of three large-scale
projects generating FLP-FRT deletions. The Exelixis and
DrosDel Projects also generated extensive genomic cov-
erage, but our project is distinguished by its emphasis
on improving deletion coverage by minimizing unde-
leted regions containing haploinsufficient genes and by
its emphasis on genomic subdivision. Haplolethal and
haplosterile loci were not a big consideration in the
planning of the Exelixis deletions while the relatively
low density of the DrosDel FRT-bearing transposons
across the genome did not, on average, allow the Dros-
Del deletions to confine haploinsufficient genes to small
undeleted intervals. Our project stressed flanking hap-
loinsufficient genes as closely as possible with pairs of
deletions as the most practical approach to improving
deletion coverage even before we started using the FLP-
FRT system. The deletions we generated by the hybrid
element insertion method [5] were also designed to pro-
vide novel coverage. Our attention to haploinsufficient
genes is largely responsible for improving overall gen-
ome coverage beyond that provided by either the older
deletions or the DrosDel and Exelixis collections. It has
also helped produce the most comprehensive inventory
of haploinsufficient genes to date in Drosophila or any
other multicellular eukaryote.
The first chromosomal deletion was discovered in D.
melanogaster [29] and Drosophila now boasts the best
genomic deletion coverage and subdivision of any ani-
mal. Total coverage is even roughly equivalent to that in
the yeasts Saccharomyces cerevisiae and Schizosaccaro-
myces pombe, where high-throughput homologous
recombination approaches are available [30,31]. Despite
this accomplishment, our approach of flanking haploin-
sufficient genes as closely as possible with deletions,
rather than first producing new duplications and subse-
quently using them in deletion screens, precluded com-
plete genomic coverage. The recent generation of X and
second chromosome duplications [9,21] and the devel-
opment of FC31 transformation technology for the
creation of new multigene duplications [25,32] will
make it much easier to isolate deletions for chromoso-
mal regions containing haploinsufficient genes. Further
improvements in deletion coverage will doubtlessly
occur as these resources and techniques are exploited.
It is remarkable how few haploinsufficient genes are
present in the D. melanogaster genome - particularly
when one considers that the vast majority fall into a sin-
gle class, the Minute genes, and produce a consistent set
of phenotypes. {AU comment: It seems to me than an
em dash should be used rather than a hyphen.} There
are very few haplolethal or haplosterile genes of any
kind. In fact, most deletions in Drosophila appear to
have no dominant phenotypic effect and, on average,
one-twentieth of a chromosome arm must be deleted
before significant aneuploidy-associated phenotypes are
seen [33,34]. This stands in stark contrast to humans,
where haploinsufficiency causes hundreds of genetic dis-
eases [35-38]. Even though the Drosophila genome has
never been systematically surveyed for weak fitness
effects arising from reduced gene dosage and one could
argue that subtle mutant phenotypes are more easily
recognized in humans, the tolerance Drosophila shows
to hypoploidy must reflect fundamental differences in
the abilities of organisms to compensate for changes in
gene dosage.
The extensive genomic coverage and subdivision pro-
vided by molecularly defined deletions in Drosophila
presents researchers with the ability to map mutations
and genetic modifiers to very small chromosomal inter-
vals with a few rounds of simple crosses. While it is
sometimes necessary to generate additional deletions for
further localization, it is often possible to identify an
obvious candidate based on its sequence characteristics
or previously characterized mutant phenotypes. Gene
identification is much easier and more efficient than it
was even a decade ago.
The mapping of X-linked mutations and modifiers
benefits from the X chromosome deletions described
here as well as duplications of X chromosomes that
were generated at the BDSC in a concurrent project
[21]. We have now isolated Y-linked duplications for
97% of the X chromosome (data not shown). These
duplications can be paired with X chromosome dele-
tions to allow inheritance of the deletions from fathers
(indeed many stocks with deletion-duplication pairs are
already distributed by the BDSC) and they can be used
to map mutations by phenotypic rescue and identify
hyperploid modifiers. Using the molecularly defined X
chromosome deletions, the Y-linked X chromosome
duplications and interchromosomal duplications of X
segments generated by FC31 transformation [25], phe-
notypes can be mapped with near single-gene resolution.
Cook et al. Genome Biology 2012, 13:R21
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Conclusions
We have presented the results of a large-scale resource
development project at the BDSC. We substantially
improved the overall genomic coverage provided by
chromosomal deletions as well as the density of deletion
breakpoints. Our efforts will simplify experiments utiliz-
ing deletions to map mutations or identify dosage-sensi-
tive enhancers and suppressors of mutant phenotypes.
To aid researchers in conducting such experiments effi-
ciently, we organized deletions providing maximal geno-
mic coverage into a Deficiency Kit. We also made a
complete inventory of haplolethal and haplosterile genes
and compiled information about other haploinsufficient
genes in D. melanogaster in the process of improving
deletion coverage. This information should contribute to
future studies of gene dosage relationships and aneu-
ploidy effects.
Chromosomal deletions are one of the most versatile
and important genetic tools available to Drosophila
researchers and the stocks generated in this project will
contribute to the success of experimental studies for
years to come. Resource development projects like ours
and their targeted funding propel research by creating
new experimental opportunities and they are vital to the




Most P{XP}, PBac{WH} and PBac{RB} insertions used in
deletion screens were obtained directly from Exelixis,
Inc. The remainder came from the BDSC and the Exe-
lixis collection at Harvard University. Other stocks came
from Exelixis, the BDSC, the Harvard collection, the
Szeged Stock Centre, the Drosophila Genetic Resource
Center at the Kyoto Institute of Technology and the
laboratory of Michael Ashburner at the University of
Cambridge.
Chromosomal positions
All genomic coordinates and gene counts are based on
Genome Release 5.16. Cytological band positions were
predicted from Release 5 coordinates using FlyBase map
conversion tables [39,40]. We artificially defined the
euchromatin/heterochromatin boundary as the most
proximal extent of the contiguous genomic assembly for
each chromosome arm in Genome Release 5.
The genomic coordinates of P{XP}, PBac{WH} and
PBac{RB} insertions were initially determined at Exelixis
and most were published in Thibault et al.[10]. Coordi-
nates of unpublished insertions were obtained directly
from Exelixis. Flanking sequences were reanalyzed by
Roger Hoskins and Joe Carlson of Lawrence Berkeley
National Laboratory and they submitted revised coordi-
nates for many insertions to FlyBase. We used these rea-
nalyzed coordinates where available. Otherwise, we used
coordinates from a preliminary reanalysis (R Hoskins,
personal communication) or the original Exelixis coordi-
nates in that order of preference. The origins of coordi-
nates are recorded in Additional file 1.
Deletion screens
Parks et al.[5] described methods for using P{XP}, PBac
{WH} and PBac{RB} insertions to isolate chromosomal
deletions in a standard genetic background. We followed
the basic schemes developed at Exelixis for deletion
screening, but we introduced some alternative stocks to
improve the vigor of flies in the crosses and final dele-
tion stocks. We built these stocks by carefully introgres-
sing balancer and marker chromosomes into the
standard background using chromosome substitution
schemes patterned on Craymer [41]. The source of the
Y and fourth chromosomes was not controlled. (Details
of stock constructions will be provided upon request.)
Here we present the crosses we eventually found to
work best for the isolation of X, second and third chro-
mosome deletions. We identified deletions based on loss
of miniwhite or the presence of two copies of miniwhite;
see Park et al.[5] and Results for the rationale. Tn{w+}1
and Tn{w+}2 are used generically to denote different
miniwhite-marked transposon (Tn) insertions of P{XP},
PBac{WH} and PBac{RB}. Deletions were named with a
BSC (Bloomington Stock Center) prefix followed by a
number in the order they were placed into public
distribution.
X chromosome deletions
G0: w1118 Tn{w+}1 ♀♀ × w1118/Y; MKRS, P{hsFLP}86E/
TM6B, Tb1 ♂♂ (9 vials of 8 ♀♀ × 5 ♂♂, subcultured
once).
G1: w1118 Tn{w+}2 ♀♀ × w1118 Tn{w+}1/Y; +/MKRS, P
{hsFLP}86E ♂♂ (9 vials of 8 ♀♀ × 5 ♂♂, subcultured once).
G2: w1118 Tn{w+}2/w1118 Tn{w+}1; +/MKRS, P{hsFLP}
86E ♀♀ × FM7h/Dp(2;Y)G, P{hs-hid}Y ♂♂ (9 vials of 8
♀♀ × 5 ♂♂, subcultured once; these females were heat
shocked as larvae at 37°C for 1 hour on days 4 to 8
after egg lay).
G3: Df(1)BSC, w1118/FM7h ♀ × FM7h/Dp(2;Y)G, P{hs-
hid}Y ♂♂ (deletion-bearing females were recognized as
white-eyed or darker-eyed flies, depending on the
screen; we typically established stocks of five indepen-
dent putative deletions for testing).
Although the temperature-sensitive lethal P{hs-hid}
construct can be used to eliminate unwanted progeny
classes, it was incidental to our choice of stocks in the
preceding and succeeding crosses and not used. We
include it here only for completeness.
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Second chromosome deletions {3rd level heading}
G0: P{hsFLP}1, y1 w1118; P{hs-hid}2, wgSp-1/CyO ♀♀ ×
w1118; Tn{w+}1 ♂♂ (5 vials of 8 ♀♀ × 5 ♂♂, subcul-
tured once).
G1: P{hsFLP}1, y1 w1118/w1118; CyO/Tn{w+}1 ♀♀ ×
w1118 /Y; Tn{w+}2 ♂♂ (5 vials of 8 ♀♀ × 5 ♂♂, subcul-
tured once).
G2: w1118; wgSp-1/SM6a ♀♀ × P{hsFLP}1, y1 w1118/Y;
Tn{w+}1/Tn{w+}2 ♂♂ (5 vials of 8 ♀♀ × 5 ♂♂, subcul-
tured once; these males were heat shocked as larvae at
37°C for 1 hour on days 4 to 8 after egg lay).
G3: w1118; wgSp-1/SM6a ♀♀ × w1118/Y; Df(2)BSC/
SM6a ♂ (deletion-bearing males were recognized as
white-eyed or darker-eyed flies, depending on the
screen; we typically established stocks of five indepen-
dent putative deletions for testing.)
G4: w1118; Df(2)BSC/SM6a ♀♀ × w1118; Df(2)BSC/
SM6a ♂♂.
Third chromosome deletions {3rd level heading}
G0: P{hsFLP}1, y1 w1118; Dr1/TM3, Sb1 ♀♀ × w1118; Tn
{w+}1 ♂♂ (5 vials of 8 ♀♀ × 5 ♂♂, subcultured once).
G1: P{hsFLP}1, y1 w1118/w1118; TM3, Sb1/Tn{w+}1 ♀♀
× w1118/Y; Tn{w+}2 ♂♂ (5 vials of 8 ♀♀ × 5 ♂♂, sub-
cultured once).
G2: w1118; P{hs-hid}3, Dr1/TM6C, cu1 Sb1 ♀♀ × P
{hsFLP}1, y1 w1118/Y; Tn{w+}1/Tn{w+}2 ♂♂
(5 vials of 8 ♀♀ × 5 ♂♂, subcultured once; these
males were heat shocked as larvae at 37°C for 1 hour on
days 4 to 8 after egg lay).
G3: w1118; P{hs-hid}3, Dr1/TM6C, cu1 Sb1 ♀♀ × w1118/
Y; Df(3)BSC/TM6C, cu1 Sb1 ♂ (deletion-bearing males
were recognized as white-eyed or darker-eyed flies,
depending on the screen; we typically established stocks
of five independent putative deletions for testing).
G4: w1118; Df(3)BSC/TM6C, cu1 Sb1 ♀♀ × w1118; Df(3)
BSC/TM6C, cu1 Sb1 ♂♂.
It was necessary to establish stocks of a few deletions
in nonstandardized backgrounds to overcome problems
arising from noncomplementation or haploinsufficiency,
but these stocks are noted in Additional file 1 and
BDSC stock records.
Verifying new deletions
Four approaches were used to verify that the planned
deletion was recovered from a screen: complementation
tests, polytene chromosome cytology, ‘hybrid PCR’ and
PCR with primers flanking transposable element inser-
tions. The complementation tests were routine and
require no elaboration. Polytene chromosomes were
analyzed in standard lacto-aceto-orcein preparations
[42] using the maps of Lefevre [43] and Sorsa et al.
[44,45].
The ‘hybrid PCR’ approach was described in Parks et
al.[5]. Briefly, primers were used to amplify a DNA
fragment from the recombinant transposable element
formed upon FLP-mediated recombination between two
progenitor FRT-bearing insertions. We used the primers
described in Parks et al.[5] with the substitution of a
new primer (5’-GCTTCTAAACGCTTACGCATAAAC
GATG-3’) for the RB3’ plus and RB3’ minus primer. We
were unable to establish Hybrid PCR primers and condi-
tions to verify deletions identified from an increase in
miniwhite copy number; consequently, we tested only
deletions detected by loss of miniwhite markers.
To verify that a particular chromosomal region was
removed by a deletion, we designed PCR primers flank-
ing the insertion site of a transposon located within the
deleted region. From crosses, we isolated progeny carry-
ing both the transposon and the putative deficiency and
isolated DNA. With short extension times, a PCR frag-
ment is amplified only when there is no transposon
between the primer sites; consequently, a fragment is
recovered if the noninsertion chromosome lacks a dele-
tion. Since this approach verifies a deletion by a negative
result, we repeated the test with three to five indepen-
dent DNA preparations and appropriate positive con-
trols. Transposon insertions and primer sequences used
in these tests are given in Additional file 1. Additional
details are available from Cook et al.[21] where similar
tests were used to confirm chromosomal duplications.
Stocks were placed into public distribution by the
BDSC as soon as we verified deletions. We submitted a
description of each deletion to FlyBase and Additional
file 1 provides citations to these reports.
Stock availability
Stocks described in this paper may be obtained from the
BDSC. Information on ordering, web pages devoted to
deletion collections and the Deficiency Kit and lists of
other stocks are available on the BDSC website [46]. Fly-
Base [39] provides information on individual genetic
components with cross references to BDSC stocks.
Additional material
Additional file 1: Breakpoints and characterization of BSC deletions.
This file provides full information for deletions isolated in this project,
including progenitor FRT insertions and their locations, selection criteria
in screens, verification tests and references to FlyBase documentation.
Additional file 2: Map of X and fourth chromosome deletion
breakpoints. This spreadsheet shows the breakpoints and progenitor
FRT insertions of Exelixis, DrosDel and BSC deletions positioned relative
to the proximal and distal ends of annotated genes. It also shows the
breakpoints of other deletions in the BDSC Deficiency Kit. The filled-in
cells in columns to the right depict deletions graphically. Similarly, the
positions of haploinsufficient genes are highlighted in colored rows to
show their relationships to the deletions. Notes explain how we
estimated the positions of breakpoints for deletions in the Deficiency Kit
that have not been molecularly characterized.
Additional file 3: Haploinsufficient genes with viability and fertility
effects. This table gives details of the mapping and identification of
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haplolethal and haplosterile genes in D. melanogaster, including
cytological locations, hemizygous phenotypes, deletions removing the
genes, deletions most closely flanking the genes and the number of
closely linked genes sharing the same deletion breakpoint interval.
Additional file 4: Bloomington Drosophila Stock Center Deficiency
Kit stocks. This file lists the component deletions in the BDSC Deficiency
Kit with their breakpoints and stock information.
Abbreviations
BDSC: Bloomington Drosophila Stock Center; FLP: FLP recombinase; FRT: FLP
recognition target; PCR: polymerase chain reaction; SNP: single-nucleotide
polymorphism.
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